BioInformant

Your Global Leader in Stem Cell Market Research

MENUMENU
  • Blog
    • Interviews
  • News
  • Stem Cells
    • iPS Cells
    • MSCs
    • HSCs
    • Adipose SCs
    • Neural Stem Cells
  • Exosomes
  • CAR-T
  • Cord Blood
  • Shop
    • Products
    • Submit PR
    • Advertise
  • About
    • Testimonials
    • Story
    • Guarantee
    • Contact
  • Home
  • Blog
    • Stem Cells
      • HSCs
      • iPS Cells
      • MSCs
      • Neural Stem Cells
      • Adipose SCs
    • Exosomes
    • Cell Therapy
      • CAR-T
    • Cord Blood
    • Stem Cell News
    • Interviews
  • COVID-19
  • Shop
  • Submit PR
  • Company
    • Advertise
    • Testimonials
    • Story
    • Job Posts
    • Guarantee
    • Privacy Policy
    • Contact

3 Bullet Thursday – Stem Cells (September 3, 2015)

September 3, 2015 By Cade Hildreth (CEO) Leave a Comment

3 Bullet Thursday, Stem Cells

Stay alert to the latest and greatest on stem cells!  Enjoy this week’s “3 Bullet Thursday,” a weekly post that we do to update you on fun and fascinating findings within the world of stem cells.

(1) This press release has gone viral since it was released two days ago. Major news for the iPSC industry! [Read more…]

Filed Under: Cord Blood, Stem Cells Tagged With: 3 bullet thursday, cord blood, market news, metrics, social media metrics, stem cells, updates

BioInformant is Honored to Sponsor the Perinatal Stem Cell Society Conference

September 2, 2015 By Cade Hildreth (CEO) Leave a Comment

Perinatal Stem Cell Conference

BioInformant is  honored to be a sponsor for the upcoming “Perinatal Stem Cell Society Conference” in Aspen, Colorado, over March 2-4, 2016. This 3-day event will feature the world’s leading perinatal stem cell researchers, specializing in Amnion, Amniotic fluid, Cord Blood for Regenerative Medicine, Cord Tissue, and the Placenta. BioInformant’s sponsorship of the event is in collaboration with Save the Cord Foundation, as part of our partnership  to promote cord blood banking awareness around the world.

The Perinatal Stem Cell Society was founded on the basic principle that stem cells from perinatal tissues contain enormous, untapped life potential to treat many disorders. It will be hosting a scientific program with topics covering all aspects of the perinatal stem cell field. Attendees are actively advancing perinatal stem cell research, and focused on paths towards treatment. [Read more…]

Filed Under: Cord Blood, Stem Cells Tagged With: bioinformant, C. Randal Mills, Joanne Kurtzberg, Perinatal Stem Cell Society, Perinatal Stem Cell Society Conference, Robert Hariri

CDI, a FUJIFILM company, Announces Launch of World’s Largest Public Stem Cell Bank

September 1, 2015 By Cade Hildreth (CEO) Leave a Comment

CDI, a FUJIFILM company, announces launch of the world's largest public stem cell bank

Cellular Dynamics International Announces Launch of CIRM hPSC Repository and First 300 iPSC Lines

Cellular Dynamics International (CDI), a FUJIFILM company since March of 2015, announced news today that has reverberated throughout the stem cell community, suggesting hope and progress for the future of stem cell research.
Cellular Dynamics International, owned by parent company FUJIFILM HoldingsAs an indisputable leader in the the manufacture and production of iPS cell products, Cellular Dynamics was awarded a $16 million grant by the California Institute of Regenerative Medicine in March of 2013. In that landmark funding awarded, CIRM allocated $16 million for CDI to create 3 induced pluripotent stem cell (iPSC) lines from 3000 healthy and diseased donors. At the same time, CIRM awarded Coriell Institute approximately $10 million to structure and store the iPSC lines within a secure biobanking facility, of which CDI was to be a “primary subcontractor.” [Read more…]

Filed Under: iPS Cells, Stem Cells Tagged With: biobanking, Cellular Dynamics International, CIRM, induced pluripotent stem cells, iPS cells, iPSC, iPSC bank

Do You Know the Top 5 iPS Cell Influencers (Right Now)?

August 26, 2015 By Cade Hildreth (CEO) 1 Comment

Since induced pluripotent stem cells (iPSCs) were first produced in 2006 from mouse cells and in 2007 from human cells, scientists have recognized the incredible potential of the cell type, including their utility in drug and toxicology screening, disease modeling, and cellular therapy applications ranging from gene correction, to whole tissue regeneration, individualized medicine, and more. Given the financial potential of the cell type, it is important to have strategies for accessing key individuals, events, and iPSC facilities.
[Read more…]

Filed Under: iPS Cells, Stem Cells Tagged With: Cellular Dynamics International, iPSC, Masayo Takahashi, Ocata Therapeutics, ReproCELL, RIKEN Center, Robert Lanza

Deal-Making within the Induced Pluripotent Stem Cell (iPS Cell) Industry

August 18, 2015 By Cade Hildreth (CEO) Leave a Comment

PROOF THAT DEAL-MAKING IS ALIVE WITHIN THE INDUCED PLURIPOTENT STEM CELL MARKETPLACE

In this post, we explore seven momentous partnerships that have been formed for purposes of strengthening company dominance within the induced pluripotent stem cell (iPS cell or iPSC) industry.  As you’ll discover, a major theme among the “power players” within the iPSC marketplace is non-exclusive agreements with iPS Academia Japan.

These non-exclusive agreements allow companies access to an absolutely critical iPSC patent portfolio by granting access to the patented discoveries of Dr. Shinya Yamanaka, the scientist who invented induced pluripotent stem cells in 2006.

[Read more…]

Filed Under: iPS Cells, Stem Cells Tagged With: ArunA Biomedical, CeeTox, Cellular Dynamics International, EMD Millipore, Fujifilm Holdings, induced pluripotent stem cell, iPSC, Life Technologies, Lonza Group AG, Roslin Cells, Sigma Aldrich

  • « Previous Page
  • 1
  • …
  • 257
  • 258
  • 259
  • 260
  • 261
  • …
  • 273
  • Next Page »

Nanocellect

Marathon Products

Kimera Society

Let’s Get Social

  • Facebook
  • Twitter
  • LinkedIn
  • Pinterest
  • Instagram

Cart

Featured Posts

iPSC derived cell therapeutics

The Pipeline for iPSC-Derived Cell Therapeutics in 2022

Stem cell companies

List of Stem Cell Companies Worldwide (2022)

Feature | Exosome Companies | Exosome Companies | Tiny Exosomes, Enormous Potential

List of Exosome Companies: Tiny Packages, Enormous Potential

My Tweets

BioInformant's World-Class Clients

  • Submit Press Release
  • Advertise
  • Privacy and Terms

Copyright © 2022 · BIOINFORMANT, Your Global Leader in Stem Cell Market Research

| Email: [email protected] | Phone: 703-859-7617 |

800 Corporate Drive, Suite 301, Stafford, VA 22554, United States

Disclaimer: All statements made on this website are NOT expressed as medical claims or advice. They are not intended to diagnose, treat, cure or prevent any disease or condition. If you have a health condition or concern, consult your physician or health care provider.